Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

11.10
Delayed Data
As of 3:59pm ET
 -0.10 / -0.89%
Today’s Change
9.59
Today|||52-Week Range
17.55
-18.08%
Year-to-Date
Sunesis Offers Updates on SNS-062 and Qinprezo Programs
4:41pm / Zacks.com - Paid Partner Content
Allergan (AGN) Rhofade Cream for Rosacea Approved in U.S.
Jan 20 / Zacks.com - Paid Partner Content
Gilead (GILD) HCV Therapy Application Validated in Europe
Jan 23 / Zacks.com - Paid Partner Content
Apricus (APRI) Stock Gains on Vitaros' Approval in Mexico
Jan 19 / Zacks.com - Paid Partner Content
Bristol-Myers Settles Litigation with Merck for Keytruda
Jan 23 / Zacks.com - Paid Partner Content
Bioblast (ORPN) SCA3 Drug Favorable in Phase IIa Study
Jan 19 / Zacks.com - Paid Partner Content
Prima Biomed Initiates Randomized Study for Breast Cancer
Jan 23 / Zacks.com - Paid Partner Content
Agenus, NCI Ink Deal to Evaluate Prophage-Keytruda Combo
Jan 18 / Zacks.com - Paid Partner Content
Synergy (SGYP) Trulance Wins FDA Approval for Constipation
Jan 20 / Zacks.com - Paid Partner Content
Benitec Stock Up on Orphan Drug Status for BB-301 in EU
Jan 18 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close11.20
Today’s open11.25
Day’s range10.75 - 11.40
Volume2,296,530
Average volume (3 months)752,594
Market cap$513.4M
Dividend yield--
Data as of 3:59pm ET, 01/24/2017

Growth & Valuation

Earnings growth (last year)+151.72%
Earnings growth (this year)+28.01%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+32.68%
P/E ratio38.3
Price/Sales5.16
Price/Book5.90

Competitors

 Today’s
change
Today’s
% change
VSARVersartis Inc+0.05+0.34%
RETAReata Pharmaceutical...+0.38+1.64%
SCLNSciClone Pharmaceuti...+0.03+0.24%
HSKAHeska Corp+1.12+1.42%
Data as of 4:00pm ET, 01/24/2017

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)$0.48
Annual revenue (last year)$153.2M
Annual profit (last year)$33.4M
Net profit margin21.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Peter S. Greenleaf
Chief Financial Officer
Andrew P. Smith
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs